Satsuma Pharmaceuticals I... (STSA)

NASDAQ: STSA · Real-Time Price · USD

1.10

0.00 (0.00%)

At close: Jun 07, 2023, 8:00 PM

Satsuma Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q4 2018
Period Ending	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Dec 31, 2018
Cash & Equivalents	19.53M	16.43M	40.56M	23.76M	21.36M	15.84M	42.26M	53.86M	102.22M	36.33M	41.52M	32.13M	22.9M	22.75M	77.66M	47.62M	5.21M
Short-Term Investments	21.84M	36.05M	23.88M	44.3M	57.15M	77.31M	65.25M	67.3M	30.9M	31.91M	40.58M	61.57M	77.88M	84.94M	41.28M	7.42M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	2.08M	n/a	2.63M	n/a	n/a	n/a	n/a	n/a	3.34M	10.2M	n/a	n/a	n/a
Other Long-Term Assets	22K	22K	551K	565K	521K	-6.79M	2.03M	1.96M	636K	774K	712K	568K	467K	497K	76K	1.28M	532K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2M	2.33M	3.13M	4.41M	5.57M	84.01M	2.44M	5.06M	3.29M	5.55M	7.95M	7.04M	8.1M	7.05M	7.63M	3.85M	199K
Total Current Assets	43.38M	54.81M	67.56M	72.47M	84.08M	93.15M	109.96M	126.23M	136.41M	73.79M	90.05M	100.74M	108.88M	114.74M	126.58M	58.89M	5.4M
Property-Plant & Equipment	82K	108K	6.92M	7.11M	6.98M	6.79M	7.67M	7.13M	7.01M	6.47M	1.45M	1.31M	1.03M	832K	885K	404K	445K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	104K	130K	7.47M	7.68M	9.59M	6.79M	12.34M	9.09M	7.64M	7.25M	2.17M	1.88M	4.84M	11.53M	961K	1.68M	977K
Total Assets	43.48M	54.94M	75.04M	80.15M	93.67M	109.83M	122.3M	135.32M	144.06M	81.03M	92.22M	102.61M	113.72M	126.28M	127.54M	60.57M	6.38M
Account Payables	874K	1.91M	1.94M	1.63M	1.8M	1.47M	1.65M	3.11M	1.14M	3.38M	3.28M	2.56M	3.44M	4.28M	2.6M	1.14M	327K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	116K	138K	172K	135K	719K	1.08M	1.57M	2.06M	1.99M	1.99M	1.99M	1.99M	1.98M	1.98M	1.64M	1.14M	141K
Other Current Liabilities	4.84M	6.07M	4.55M	6.13M	4.07M	5.94M	3.4M	2.41M	2.21M	2.67M	2.43M	2.12M	1.81M	1.71M	1.69M	2.19M	1.5M
Total Current Liabilities	5.83M	8.12M	6.66M	7.89M	6.58M	8.49M	6.62M	7.58M	5.35M	8.05M	7.69M	6.67M	7.23M	7.97M	5.94M	4.47M	1.97M
Long-Term Debt	n/a	n/a	n/a	70K	104K	n/a	n/a	n/a	556K	1.04M	1.52M	2M	2.48M	2.95M	3.42M	3.89M	4.82M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5K	7K	9K	11K	13K	15K	19K	66K	70K	11.72M
Total Long-Term Liabilities	990K	2.05M	2.11M	70K	104K	n/a	n/a	5K	563K	1.05M	1.53M	2.02M	2.49M	2.97M	3.48M	3.96M	16.55M
Total Liabilities	5.83M	8.12M	6.66M	7.96M	6.69M	8.49M	6.62M	7.58M	5.91M	9.1M	9.23M	8.68M	9.73M	10.94M	9.42M	8.42M	18.51M
Total Debt	116K	138K	172K	205K	823K	1.08M	1.57M	2.06M	2.55M	3.03M	3.51M	3.99M	4.46M	4.93M	5.06M	5.03M	4.96M
Common Stock	3K	3K	3K	3K	3K	3K	3K	3K	3K	2K	2K	2K	2K	2K	3K	5K	1K
Retained Earnings	-222.09M	-211.79M	-188.66M	-173.52M	-157.25M	-141.74M	-126.19M	-112.85M	-101.02M	-90.56M	-78.09M	-66.04M	-54.77M	-43M	-32.19M	-23.93M	-14.83M
Comprehensive Income	-5K	-30K	-63K	-107K	-121K	-42K	-12K	-5K	3K	29K	85K	235K	-15K	17K	12K	n/a	-67K
Shareholders Equity	37.65M	-211.79M	68.38M	72.19M	86.98M	101.34M	115.67M	127.74M	138.15M	71.94M	82.99M	93.93M	103.99M	115.33M	118.12M	52.15M	-12.13M
Total Investments	21.84M	36.05M	23.88M	44.3M	59.24M	77.31M	67.89M	67.3M	30.9M	31.91M	40.58M	61.57M	81.22M	95.14M	41.28M	7.42M	n/a